Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

DNA Genotek, Inc. · Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

266 daysmedian FDA review time
506 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K254121Colli-Pee•Dx Urine Collection KitDNA Genotek, Inc.2026-06-101730
K212745ORAcollect®•DxDNA Genotek, Inc.2022-10-274230
DEN200040OMNIgene GUT DxDNA Genotek, Inc.2021-11-035060
K192920Oragene®•DxDNA Genotek, Inc.2020-01-14900
K152464ORAcollect.DxDNA Genotek, Inc.2016-05-262690
K152556Oragene DxDNA Genotek, Inc.2016-05-262610
K141410ORAGENE DX OGD-500.001DNA Genotek, Inc.2015-02-192660
K110701ORAGENE-DX OGD-500; ORAGENE-DX OGD-575; ORAGENE-DX OXD-525; DNA Genotek, Inc.2011-12-022630

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda